Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

Eastern North Carolina's biomanufacturing sector is experiencing unprecedented growth, with the region capturing the lion's ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $10.48 / share. This is a decrease ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

A biotechnology company with major plans to develop obesity drugs celebrated its arrival in the Triangle on Monday. San Francisco-based Genentech plans to create up to 420 high-paying jobs in Holly ...

Milwaukee Area Technical College unveiled a 2,000 square foot biotech classroom and lab at its downtown campus to train students starting in spring 2026.

PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on ...